Final Report of the Cosmetic Ingredient Review Expert Panel Safety Assessment of Polymethyl Methacrylate (PMMA), Methyl Methacrylate Crosspolymer, and Methyl Methacrylate/Glycol Dimethacrylate Crosspolymer

被引：25
作者：
Becker, Lillian C. [1 ]
Bergfeld, Wilma F.
Belsito, Donald V.
Hill, Ronald A.
Klaassen, Curtis D.
Liebler, Daniel C.
Marks, James G., Jr.
Shank, Ronald C.
Slaga, Thomas J.
Snyder, Paul W.
Andersen, F. Alan [1 ]
机构：
[1] Cosmet Ingredient Rev, Washington, DC 20036 USA
来源：
INTERNATIONAL JOURNAL OF TOXICOLOGY | 2011年 / 30卷
关键词：
cosmetics; methyl methacrylate/glycol dimethacrylate crosspolymer; polymethyl methacrylate; safety; POLYMETHYLMETHACRYLATE; RELEASE;
D O I：
10.1177/1091581811407352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Polymethyl methacrylate (PMMA) and related cosmetic ingredients methyl methacrylate crosspolymer and methyl methacrylate/glycol dimethacrylate crosspolymer are polymers that function as film formers and viscosity-increasing agents in cosmetics. The Food and Drug Administration (FDA) determination of safety of PMMA use in several medical devices, which included human and animal safety data, was used as the basis of safety of PMMA and related polymers in cosmetics by the Cosmetic Ingredient Review (CIR) Expert Panel. The PMMA used in cosmetics is substantially the same as in medical devices. The Panel concluded that these ingredients are safe as cosmetic ingredients in the practices of use and concentrations as described in this safety assessment.
引用
收藏
页码：54S / 65S
页数：12
相关论文
共 77 条
[61]  
SCHOON D, 2010, BRIEF OVERVIEW POLYM
[62]  
Sugaya H, 1999, CONTRIB NEPHROL, V125, P1
[63]  
Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
[64]  
U. S. Food and Drug Administration, 2003, GEN PLAST SURG DEV P
[65]  
*US FDA, 2002, K021715 US FDA, P1
[66]  
*US FDA, 2004, K033563 US FDA, P1
[67]  
*US FDA, 2000, P980040 US FDA, P1
[68]  
*US FDA, 2007, K091548 US FDA, P1
[69]  
*US FDA, 2002, CLASS 2 SPEC CONTR G
[70]  
*US FDA, 2009, FDA DAT COSM PROD FO
12345678